Job/Unit: O50237
/KAP1
Date: 05-05-15 12:22:36
Pages: 7
Reactivity of Zerumbone and Related Dienones
4-H2), 1.90 (m, 1 H, 1b-H), 1.92 (s, 3 H, 13-H3), 1.40 (s, 3 H, 12- Cytotoxicity Assays: SK-S-NH cells were seeded at a density of
H3), 1.07 (s, 6 H, 14-H3, 15-H3) ppm. 13C NMR (CDCl3, 104 cells/well in 96-well plates (200 μL), and were incubated with
125 MHz): δ = 201.6 (C-8), 151.6 (C-6), 143.6 (C-10), 137.5 (C-7), increasing concentrations of the compounds for 24 h. After that,
134.2 (C-3), 127.3 (C-9), 126.2 (C-2), 41.7 (C-11), 40.8 (C-1), 38.6 MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium brom-
(C-4), 33.5 (C-5), 29.0 (C-14), 25.1 (C-15), 10.7 (C-13), 15.6 (C-12) ide); 5 mg/mL; 100 μL] from a mixed solution of MTT and DMEM
ppm. MS (ESI+): m/z = 241 [M + Na]+. HRMS (ESI+): calcd. for
C15H22ONa 241.1568; found 241.1570.
(Dulbecco’s modified Eagle medium) (1:2) was added to each well,
and cells were incubated at 37 °C in the dark for 4 h. Then the
reaction was stopped, the supernatant was removed, DMSO
(100 μL) was added to each well, and the wells were incubated for
10 min with gentle shaking. Finally, the absorbance was measured
at 550 nm by using a TriStar LB 941 instrument (Berthold Technol-
ogies). The absorbance of untreated cells was taken as 100%
viability, and the percentage of cellular viability was calculated.
(6Z,9Z)-Diisozerumbone (1c): Colourless powder, m.p. 75–77 °C.
1H NMR (CDCl3, 500 MHz): δ = 6.60 (m, 1 H, 6-H), 5.99 (d, J =
12.2 Hz, 1 H, 9-H), 5.60 (d, J = 12.2 Hz, 1 H, 10-H), 5.18 (t, J =
8.1 Hz, 1 H, 2-H), 2.41 (m, 2 H, 5-H2), 2.30 (m, 2 H, 4-H2), 2.05–
1.95 (m, 2 H, 1-H2), 1.75 (s, 3 H, 13-H3), 1.53 (s, 3 H, 12-H3),
1.05 (s, 3 H, 14-H3), 0.83 (s, 3 H, 15-H3) ppm. 13C NMR (CDCl3,
125 MHz): δ = 204.8 (C-8), 144.2 (C-10), 137.5 (C-7), 136.2 (C-3),
131.5 (C-6), 126.5 (C-9), 125.0 (C-2), 43.1 (C-11), 41.6 (C-1), 38.2
(C-4), 33.5 (C-5), 29.0 (C-14), 25.1 (C-15), 21.4 (C-13), 19.7 (C-12)
ppm. MS (ESI+): m/z = 241 [M + Na]+. HRMS (ESI+): calcd. for
C15H22ONa 241.1568; found 241.1572.
NF-κB and Nrf2 Transcriptional Assays: Anti-NF-κB (NF =
nuclear factor) activity was investigated in 5.1 cells, a validated “in
vitro” model for the study of TNFα-induced NF-κB activation
(TNF = tumor necrosis factor).[22] The 5.1 cells were stimulated
with TNFα (20 ng/mL) in the presence or absence of the com-
pounds for 6 h. For the activation of the antioxidant response ele-
ment (ARE), SK-N-SH cells were transiently transfected with the
pGL3-ARE-Luc plasmid, which contains the Nqo1 antioxidant
response element fused to the luciferase reporter gene. After 24 h,
the cells were stimulated with the compounds for 6 h. After stimu-
lation, the cells were washed twice in PBS (phosphate-buffered
saline) and lysed in tris-phosphate pH = 7.8 (25 mm), MgCl2
(8 mm), DTT (1 mm), Triton X-100 (1%), and glycerol (7%) at
room temperature in a horizontal shaker for 15 min. After centri-
fugation, the supernatants were used to measure luciferase activity
by using an Autolumat LB 9510 instrument (Berthold) following
the instructions of the luciferase assay kit (Promega, Madison, WI,
USA). The protein concentration in the cell extracts was measured
by the Bradford method (BioRad, Hercules, CA, USA). The RLU/
μg (RLU = relative light units) was calculated, and the results were
expressed as percentage of inhibition of NF-κB activity induced by
TNFα (100% activation). For Nrf2 activation, the specific ARE-
Luc induction was expressed as induction relative to the control
(untreated cells).
(2Z,6Z)-Diisozerumbone (1d): Colourless powder, m.p. 56–57 °C.
1H NMR (CDCl3, 500 MHz): δ = 6.34 (d, J = 16.2 Hz, 1 H, 10-
H), 5.88 (d, J = 16.2 Hz, 1 H, 9-H), 5.53 (m, 1 H, 6-H), 5.13 (t, J
= 8.1 Hz, 1 H, 2-H), 2.31 (m, 2 H, 4-H2), 2.18 (m, 2 H, 5-H2),
2.05–1.91 (m, 2 H, 1-H2), 1.91 (s, 3 H, 13-H3), 1.69 (3 s, 3 H, 12-
H3), 1.15 (s, 3 H, 14-H3), 1.15 (s, 3 H, 15-H3) ppm. 13C NMR
(CDCl3, 125 MHz): δ = 203.8 (C-8), 161.7 (C-10), 137.5 (C-7),
137.0 (C-3), 131.5 (C-6), 127.5 (C-9), 123.8 (C-2), 42.9 (C-11), 40.1
(C-1), 37.0 (C-4), 33.5 (C-5), 29.3 (C-14), 24.2 (C-15), 21.4 (C-13),
20.7 (C-12) ppm. MS (ESI+): m/z = 241 [M + Na]+. HRMS (ESI+):
calcd. for C15H22ONa 241.1568; found 241.1565.
Epoxidation of (9Z)-Zerumbone (1b): m-Chloroperbenzoic acid
(MCPBA; 80%; 84 mg, 0.8 mmol, 2 equiv.) was added to a solution
of 1b (85 mg, 0.4 mmol) in CH2Cl2 (2 mL). The mixture was stirred
at room temp. for 15 min, then it was diluted with CH2Cl2 (10 mL),
and worked up by concentration. The residue was purified by grav-
ity column chromatography on neutral alumina (10 g; petroleum
ether/EtOAc, 8:2) to give 2b (80 mg, 93%).
(9Z)-Isozerumbone Oxide (2b): Colourless foam. 1H NMR (CDCl3,
500 MHz): δ = 6.04 (d, J = 11.8 Hz, 1 H, 10-H), 5.98 (br. t, 1 H,
6-H), 5.43 (d, J = 11.8 Hz, 9-H), 2.87 (dd, J = 7.9, 3.7 Hz, 1 H, 2-
H), 2.85 (m, 1 H, 4a-H), 2.20 (m, 2 H, 5-H2), 1.91 (s, 3 H, 13-H3),
1.82 (dd, J = 13.2, 3.7 Hz, 1 H, 1a-H), 1.25 (s, 3 H, 3 H, 12-H3),
1.18 (m, 2 H, 4b-H, 1b-H), 1.10 (s, 6 H, 14-H3, 15-H3) ppm. 13C
NMR (CDCl3, 125 MHz): δ = 202.8 (C-8), 159.6 (C-6), 147.9 (C-
10), 139.5 (C-7), 128.4 (C-9), 62.9 (C-2), 61.5 (C-3), 42.7 (C-4), 38.2
(C-1), 36.1 (C-5), 29.8 (C-14), 24.8 (C-11), 24.0 (C-15), 15.6 (C-13),
12.2 (C-12) ppm. MS (ESI+): m/z = 257 [M + Na]+. HRMS (ESI+):
calcd. for C15H22O2Na 257.3238; found 257.3244.
ROS Determination: To evaluate the induction of ROS, SK-N-SH
cells were treated with increasing concentrations of compounds for
12 h. Then the cells were incubated in PBS with DiOC6(3) (green
fluorescence; 20 nm; Molecular Probes, Eugene, OR, USA) at 37 °C
for 20 min, followed by analysis with a FACS Canto II flow cyto-
meter (Beckton Dickinson, NJ, USA).
Statistical Analysis: Data are expressed as meanϮSD. Differences
were analysed by the Student’s t test. P Ͻ 0.05 was considered
significant.
Cysteamine Assay: In a standard 5 mm NMR tube (Armar Chemi-
cals), the substrate (ca. 5 mg) was dissolved in [D6]DMSO
(500 μL), and the NMR spectrum was recorded. Cysteamine
(1.5 equiv.) was then added, and the spectrum was recorded again
5 min after the addition. A second aliquot (4 equiv.) of cysteamine
was added, and the spectrum was registered again. An aliquot
(25 μL) of the solution was then transferred into a second NMR
tube containing CDCl3 (500 μL), and a new spectrum was re-
corded. A positive assay was evidenced by the disappearance of the
dienone signals of the substrate, and the reversibility of the Michael
addition by the reappearance of some of them after dilution to 1:20
with CDCl3. Comparative reactivity experiments were carried out
by treating roughly equimolar amounts of two substrates with a
substoichiometric amount of cysteamine (0.8–1.0 equiv. based on a
single reactive site in only one of the two substrates).
Acknowledgments
We thank Dr. Daniel Joulain for a generous gift of zerumbone,
and Mr. Andry Leeman (Mensa Group, Jakarta, Indonesia) for
providing fresh zerumbet roots. We are grateful to Ministero
dell’Università e Ricerca Scientifica e Tecnologica (MURST), Italy
for financial support (Project 2009RMW3Z5: “Metodologie sintet-
iche per la generazione di diversità molecolare di rilevanza bio-
logica”). Mass and NMR spectra were recorded at the “Centro di
Servizio Interdipartimentale di Analisi Strumentale”, Università di
Napoli “Federico II”.
[1] J. Singh, R. C. Petter, T. A. Baillie, A. Whitty, Nat. Rev. Drug
Discovery 2011, 10, 307–17.
Eur. J. Org. Chem. 0000, 0–0
© 0000 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
5